Hangzhou AGS Medtech(688581.SH) granted 391,500 restricted shares at a price of 70 yuan per share.

18:42 07/09/2023

Hangzhou AGS Medtech(688581.SH) announcement, the restrictive stock grant conditions stipulated in the company's 2023 restricted stock incentive plan have been achieved. The company has determined September 7, 2023 as the initial grant date for the restricted stocks of this equity incentive plan. It will grant 391,500 restricted stocks at a price of 70 yuan per share to 69 eligible incentive recipients.

Fuan Pharmaceutical (300194.SZ) subsidiary has received approval for a chemical raw material drug to be listed.

In late January, the total market value of domestic shares of listed companies in the upper-middle reaches reached 11.45 trillion yuan, and the total market value of the five sectors in the entire market hit a near five-year high.

Apple Inc. (AAPL.US) is in intensive discussions with three major banks in India, planning to launch Apple Pay in the market with a population of 1.4 billion.

Fuan Pharmaceutical (300194.SZ) subsidiary has received approval for a chemical raw material drug to be listed.

Apple Inc. (AAPL.US) is in intensive discussions with three major banks in India, planning to launch Apple Pay in the market with a population of 1.4 billion.